Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amnio Technology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Amnio Technology

Amnio Technology

Seed

Amnio Technology: Enhancing tissue donation and wound care through innovative regenerative solutions.

HQ
Phoenix, AZ, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance tissue donation and wound care, Amnio Technology focuses on developing and manufacturing amnion-derived technologies. Their core vision is to improve the regenerative potential and clinical application of unique tissues. The company offers a range of products, including chorion-free amniotic membranes and liquid products, under the PalinGen® brand. These products serve the unmet and underserved needs in wound care and orthopedics by providing biologic and physiologic properties that aid in tissue regeneration and protection.

Amnio Technology has made significant strides in the field of regenerative medicine, backed by years of research and development. The company is affiliated with leading experts in tissue engineering and regenerative therapies. Notable investors include key stakeholders in the biotech and medical device industries. Their innovative solutions have had a profound impact on improving patient outcomes in wound care and orthopedic applications, establishing Amnio Technology as a leader in the regenerative medicine market.

Amnio Technology - Similar Companies

AmnioLife logo

AmnioLife

Liventa Bioscience logo

Liventa Bioscience

Equine Amnio Solutions logo

Equine Amnio Solutions

renovoequine.com

BioTissue logo

BioTissue

biotissue.com

Humabiologics logo

Humabiologics

humabiologics.com

BiomedInnovations logo

BiomedInnovations

EndoCellutions logo

EndoCellutions

endocellutions.com

Amphix Bio logo

Amphix Bio

amphixbio.com

Histogen logo

Histogen

histogen.com

Antria logo

Antria

antria.org

Amplicore logo

Amplicore

42Bio logo

42Bio

42bio.com

GeniPhys logo

GeniPhys

geniphys.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Paragonix Technologies logo

Paragonix Technologies

Amnio Technology - Quick Facts

Who are Amnio Technology's competitors?

Companies similar to Amnio Technology include AmnioLife, Liventa Bioscience, Equine Amnio Solutions and BioTissue.

When was Amnio Technology founded?

Amnio Technology was founded in 2013.

Where is Amnio Technology's headquarters located?

Amnio Technology's headquarters is located in Phoenix, AZ, US.

When was Amnio Technology's last funding round?

Amnio Technology's most recent funding round was for $50k (USD) in April 2013.

How much has Amnio Technology raised to-date?

As of Apr 16, 2013, Amnio Technology has raised a total of $50k (USD).

How many employees does Amnio Technology have?

Amnio Technology has 14 employees as of Feb 5, 2024.

Amnio Technology - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified